 |
23rd
Street Cafe 6:00 to 10:00 pm Fall
KickoffManaging
People and Products in a Global EnvironmentSpeaker:
Donna Lombardo, MS Sponsor: Volunteered...that's the spirit! Good
company! Good drink! Good food! Good Program! Good
fun! THE
SPEAKER AND PROGRAM: On "retiring" from GlaxoSmithKline, Donna established her own marketing and training business, Lombardo Consulting, providing global marketing expertise and customized training programs for pharmaceutical and healthcare companies. Her program will focus on the unique challenges of building global brands. Drawing from ten years of "case studies" and anecdotes in developing and launching products in North and South America, Europe, Asia and the Mid-East, Donna will discuss the challenges, strategies and rewards of working in a global environment. Those members who were fortunate enough to hear Donna present to us a year and a half ago will agree that her presentation was filled with enthusiasm, knowledge, and professionalism.
Tuesday,
May 20, 2003
Biopharmaceutical
Scenarios ...Five
Futures for the Industry Speaker: Robert Smith Good
company! Good drink! THE
SPEAKER AND PROGRAM: Prior to his service with Dorland and its predecessors, Bob was the Associate Director of Strategy Development and Corporate Intelligence at SmithKline Beecham (now GlaxoSmithKline). During his 22 years of service with that company, Bob held various positions in Research and Development, Marketing Research, and Corporate Planning and Business Development. He was hired into the pharmaceutical industry by Dr. Herchel Smith at Wyeth in 1964 as a medicinal chemist. Bob holds a B.S. in chemistry from Loyola College, and an M.A. in medicinal chemistry and a MBA in finance, both from Temple University. He is currently an invited lecturer at Cornell University Graduate School of Business and the Wharton School at the University of Pennsylvania. His presentation on Biopharmaceutical Scenarios will suggest five futures for the biopharmaceutical industry, based on its current state and its change factors. In this talk he will include his view of the meaning of the popular phrase, personalized medicine. LIKE TO ATTEND AS A VISITOR? Call Dick Dresher for more information at
Good
company! Good drink! THE
SPEAKER AND PROGRAM: As Yogi Berra once said, "The future is hard to predict!" And that certainly applies to the pharmaceutical industry ... despite it being characterized as "data rich," but "information poor." Industry veteran, Tom Bang, will present some of the reasons we do not better understand where our products, our companies, and our industry are heading. By understanding the data, the issues, and the information processes we have available, we can better forecast the future as well as better shape it. Tom has impressive credentials. Before going to TVG in April of 2001, he was Assistant Vice President of Business Planning at Wyeth-Ayerst. His experience before that was a series of advancements with Hoffmann-La Roche as VP of Marketing Services, VP and General Manager of Pharmaceuticals in Canada, Regional Sales and Marketing Manager, Manager of Career Development, Sales Promotion Manager, Division Sales Manager, and last, but not least, Sales Representative. A real climb up the ladder of success! Tom has a BS in Business Administration from the University of Sioux Falls.
THE SPEAKER AND PROGRAM: PCCI's own Dr. Michael Fox will be traveling from his home in Boston to present this month's program. He is probably the most credentialed speaker in the history of PCCI. Never before in the history of the pharma-ceutical industry has the health-care environ-ment been so fluid. The stra-tegic issues facing manage-ment are many and involve Sales, Marketing, Finance, Medical, Manufacturing, Regulatory as well as all other facets of the industry. Dr. Fox will attempt to touch on, and discuss, those most affecting the pharmaceutical market today. Michael is board-certified in Internal and Pulmonary Medicine and is presently an Adjunct Professor of Medicine at Boston University School of Medicine and on the adjunct faculty of Tufts University Medical School/New England Medical Center. He is also the Chairman of the Clinical Research Advisory Council of ECRI (the "Consumer Reports" for the healthcare industry. In addition, Dr. Fox is the President of Healthcare Advisors, Inc., consultants to biopharmaceutical and healthcare-related industries. His background includes: President and COO of Penwest Pharmaceuticals, Inc., Sr. VP of Medical and Regulatory Affairs for Alkermens, Inc., Sr. VP of Astra USA, Sr. VP of Medical Affairs and Clinical Development at SmithKline Beecham. Dr. Fox received his B.A. from Harvard University, Bachelor of
Medical Sciences from Dartmouth Medical School, M.D. from the University
of Rochester School of Medicine, and M.B.A. from The Wharton School
of the University of Pennsylvania.
THE SPEAKER: PCCI member, Paul Schugsta, is a Senior Marketing Research Executive
with extensive experience in the pharmaceutical industry. He has
a broad strategic marketing background with US and International
experience...including Europe, Japan and China. In addition to his
primary marketing research skills, Paul has also co-designed and
conducted numerous training programs for product managers and market
research staff in key markets. Currently, he is an Independent Senior
Consultant and specializes in International Healthcare. Before his current position, Paul served as Associate Director, Marketing Research for GlaxoSmithKline. Prior to his years at SK&F and GSK, he was Manager, International Marketing Research for Wyeth Ayerst International Limited. Paul also has worked for Merck, Sharp & Dohme US in Marketing Research, Advertising Operations, Direct Mail Advertising, and Pharmaceutical Manufacturing and Packaging. Paul holds a Master Business Administration with a major in Marketing from Temple University and a Bachelor of Arts from La Salle University.
|
|
|
|
|
|
|||||||||||||||||||||||
